{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:49:46Z","timestamp":1792093786193,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11102-022-01216-0","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T10:12:50Z","timestamp":1650276770000},"page":"486-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Machine learning as a clinical decision support tool for patients with acromegaly"],"prefix":"10.1007","volume":"25","author":[{"given":"Cem","family":"Sulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayy\u00fcce Beg\u00fcm","family":"Bekta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Numan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Mefkure","family":"\u00d6zkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmettin","family":"Tanr\u0131\u00f6ver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"\u00c7omuno\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"K\u0131z\u0131lk\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurperi","family":"Gazio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-623X","authenticated-orcid":false,"given":"P\u0131nar","family":"Kad\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"issue":"11","key":"1216_CR1","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1172\/jci39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119(11):3189\u20133202 Epub 2009\/11\/04. doi: https:\/\/doi.org\/10.1172\/jci39375. PubMed PMID: 19884662; PubMed Central PMCID: PMCPMC2769196.","journal-title":"J Clin Invest"},{"issue":"1","key":"1216_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152","journal-title":"Endocr Rev"},{"issue":"3","key":"1216_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/er.2009-0033","volume":"31","author":"M Sherlock","year":"2010","unstructured":"Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC et al (2010) Mortality in patients with pituitary disease. Endocr Rev 31(3):301\u2013342","journal-title":"Endocr Rev"},{"issue":"11\/12","key":"1216_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/s-2004-814150","volume":"35","author":"AG Renehan","year":"2003","unstructured":"Renehan AG, O\u2019Connell J, O\u2019Halloran D, Shanahan F, Potten CS, O\u2019Dwyer ST et al (2003) Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res 35(11\/12):712\u2013725","journal-title":"Horm Metab Res"},{"issue":"2","key":"1216_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/neuros\/nyx020","volume":"81","author":"H Babu","year":"2017","unstructured":"Babu H, Ortega A, Nuno M, Dehghan A, Schweitzer A, Bonert HV et al (2017) Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81(2):357\u2013366","journal-title":"Neurosurgery"},{"issue":"6","key":"1216_CR6","first-page":"1239","volume":"48","author":"I Shimon","year":"2001","unstructured":"Shimon I, Cohen ZR, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6):1239\u20131245","journal-title":"Neurosurgery"},{"key":"1216_CR7","doi-asserted-by":"publisher","first-page":"106201","DOI":"10.1016\/j.clineuro.2020.106201","volume":"198","author":"S Aydin","year":"2020","unstructured":"Aydin S, Ozoner B, Sahin S, Alizada O, Comunoglu N, Oz B et al (2020) A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly. Clin Neurol Neurosurg 198:106201 Epub 2020\/09\/15. doi: https:\/\/doi.org\/10.1016\/j.clineuro.2020.106201. PubMed PMID: 32927330.","journal-title":"Clin Neurol Neurosurg"},{"key":"1216_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.wneu.2015.12.092","volume":"88","author":"O Haliloglu","year":"2016","unstructured":"Haliloglu O, Kuruoglu E, Ozkaya HM, Keskin FE, Gunaldi O, Oz B et al (2016) Multidisciplinary Approach for Acromegaly: A Single Tertiary Center\u2019s Experience. World Neurosurg 88:270\u2013276 Epub 2016\/01\/26. doi: https:\/\/doi.org\/10.1016\/j.wneu.2015.12.092. PubMed PMID: 26806060.","journal-title":"World Neurosurg"},{"issue":"5","key":"1216_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/01616412.2017.1296653","volume":"39","author":"V Briceno","year":"2017","unstructured":"Briceno V, Zaidi HA, Doucette JA, Onomichi KB, Alreshidi A, Mekary RA et al (2017) Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis. Neurol Res 39(5):387\u2013398","journal-title":"Neurol Res"},{"issue":"9","key":"1216_CR10","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane Jr","year":"2011","unstructured":"Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO et al (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metabolism 96(9):2732\u20132740","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"01","key":"1216_CR11","doi-asserted-by":"publisher","first-page":"047","DOI":"10.1055\/s-0033-1354578","volume":"75","author":"H Sun","year":"2014","unstructured":"Sun H, Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2014) Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly. J Neurol Surg Part B: Skull Base 75(01):047\u201352","journal-title":"J Neurol Surg Part B: Skull Base"},{"issue":"1","key":"1216_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/eje.1.01824","volume":"152","author":"P Petrossians","year":"2005","unstructured":"Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H et al (2005) Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. Eur J Endocrinol 152(1):61\u201366","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1216_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12020-014-0383-y","volume":"49","author":"K Kiseljak-Vassiliades","year":"2015","unstructured":"Kiseljak-Vassiliades K, Carlson NE, Borges MT, Kleinschmidt-DeMasters B, Lillehei KO, Kerr JM et al (2015) Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine 49(1):231\u2013241","journal-title":"Endocrine"},{"issue":"1","key":"1216_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04286.x","volume":"77","author":"A Heck","year":"2012","unstructured":"Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm\u2010Pettersen J et al (2012) Intensity of pituitary adenoma on T2\u2010weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol 77(1):72\u201378","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1216_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019. Eur J Endocrinol 152(3):379\u2013387","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1216_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1365-2265.1999.00760.x","volume":"50","author":"S Ahmed","year":"1999","unstructured":"Ahmed S, Elsheikh M, Stratton I, Page R, Adams C, Wass J (1999) Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50(5):561\u2013567","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1216_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00234-016-1728-4","volume":"58","author":"M Shen","year":"2016","unstructured":"Shen M, Zhang Q, Liu W, Wang M, Zhu J, Ma Z et al (2016) Predictive value of T2 relative signal intensity for response to somatostatin analogs in newly diagnosed acromegaly. Neuroradiology 58(11):1057\u20131065","journal-title":"Neuroradiology"},{"issue":"2","key":"1216_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11102-012-0395-7","volume":"16","author":"CC van Bunderen","year":"2013","unstructured":"van Bunderen CC, van Varsseveld NC, Baayen JC, van Furth WR, Aliaga ES, Hazewinkel MJ et al (2013) Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging. Pituitary 16(2):158\u2013167","journal-title":"Pituitary"},{"issue":"4","key":"1216_CR19","first-page":"163","volume":"20","author":"P Mazal","year":"2001","unstructured":"Mazal P, Czech T, Sedivy R, Aichholzer M, Wanschitz J, Klupp N et al (2001) Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients. Clin Neuropathol 20(4):163\u2013171","journal-title":"Clin Neuropathol"},{"issue":"4","key":"1216_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-10-0586","volume":"163","author":"Y Bakhtiar","year":"2010","unstructured":"Bakhtiar Y, Hirano H, Arita K, Yunoue S, Fujio S, Tominaga A et al (2010) Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. Eur J Endocrinol 163(4):531","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1216_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1530\/eje.0.1500763","volume":"150","author":"A Bourdelot","year":"2004","unstructured":"Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X et al (2004) Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Eur J Endocrinol 150(6):763\u2013771","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1216_CR22","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1210\/jc.2013-1036","volume":"98","author":"RM Starke","year":"2013","unstructured":"Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr (2013) Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metabolism 98(8):3190\u20133198","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"1216_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12020-018-1590-8","volume":"60","author":"X Antunes","year":"2018","unstructured":"Antunes X, Ventura N, Camilo GB, Wildemberg LE, Guasti A, Pereira PJM et al (2018) Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3):415\u2013422","journal-title":"Endocrine"},{"issue":"10","key":"1216_CR24","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jcem.83.10.5111","volume":"83","author":"A Abosch","year":"1998","unstructured":"Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metabolism 83(10):3411\u20133418","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1216_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.wneu.2013.01.021","volume":"81","author":"M Shirvani","year":"2014","unstructured":"Shirvani M, Motiei-Langroudi R (2014) Transsphenoidal surgery for growth hormone\u2013secreting pituitary adenomas in 130 patients. World Neurosurg 81(1):125\u2013130","journal-title":"World Neurosurg"},{"issue":"1","key":"1216_CR26","first-page":"18","volume":"3","author":"K Kovacs","year":"1986","unstructured":"Kovacs K, Horvath E (1986) Pathology of growth hormone-producing tumors of the human pituitary. Semin Diagn Pathol 3(1):18\u201333 Epub 1986\/02\/01. PubMed PMID: 3303228","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"1216_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3171\/jns.2003.98.4.0719","volume":"98","author":"MD Krieger","year":"2003","unstructured":"Krieger MD, Couldwell WT, Weiss MH (2003) Assessment of long-term remission of acromegaly following surgery. J Neurosurg 98(4):719\u2013724","journal-title":"J Neurosurg"},{"key":"1216_CR28","doi-asserted-by":"crossref","unstructured":"Dutta P, Korbonits M, Sachdeva N, Gupta P, Srinivasan A, Devgun JS et al (2016) Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly? Neurology India 64(2):252\u20138","DOI":"10.4103\/0028-3886.177622"},{"issue":"12","key":"1216_CR29","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1210\/jc.2005-0901","volume":"90","author":"R Feelders","year":"2005","unstructured":"Feelders R, Bidlingmaier M, Strasburger C, Janssen J, Uitterlinden P, Hofland L et al (2005) Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. J Clin Endocrinol Metabolism 90(12):6480\u20136489","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"6","key":"1216_CR30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3171\/2013.8.JNS13224","volume":"119","author":"DB Hazer","year":"2013","unstructured":"Hazer DB, I\u015f\u0131k S, Berker D, G\u00fcler S, G\u00fcrlek A, Y\u00fccel T et al (2013) Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. J Neurosurg 119(6):1467\u20131477","journal-title":"J Neurosurg"},{"issue":"3","key":"1216_CR31","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1097\/MJT.0b013e31827ab4a0","volume":"23","author":"TJ Cleophas","year":"2016","unstructured":"Cleophas TJ (2016) Machine learning in therapeutic research: the hard work of outlier detection in large data. Am J Ther 23(3):e837\u2013e43","journal-title":"Am J Ther"},{"issue":"5","key":"1216_CR32","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2018.8.FOCUS18268","volume":"45","author":"TC Hollon","year":"2018","unstructured":"Hollon TC, Parikh A, Pandian B, Tarpeh J, Orringer DA, Barkan AL et al (2018) A machine learning approach to predict early outcomes after pituitary adenoma surgery. NeuroSurg Focus 45(5):E8","journal-title":"NeuroSurg Focus"},{"issue":"5","key":"1216_CR33","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2018.8.FOCUS18243","volume":"45","author":"VE Staartjes","year":"2018","unstructured":"Staartjes VE, Serra C, Muscas G, Maldaner N, Akeret K, van Niftrik CH et al (2018) Utility of deep neural networks in predicting gross-total resection after transsphenoidal surgery for pituitary adenoma: a pilot study. NeuroSurg Focus 45(5):E12","journal-title":"NeuroSurg Focus"},{"issue":"2","key":"1216_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12020-019-02121-6","volume":"67","author":"Y Fan","year":"2020","unstructured":"Fan Y, Li Y, Li Y, Feng S, Bao X, Feng M et al (2020) Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly. Endocrine 67(2):412\u2013422","journal-title":"Endocrine"},{"key":"1216_CR35","doi-asserted-by":"crossref","unstructured":"Dai C, Fan Y, Li Y, Bao X, Li Y, Su M et al (2020) Development and interpretation of multiple machine learning models for predicting postoperative delayed remission of acromegaly patients during long-term follow-up.Frontiers in endocrinology. 2020;11:643.","DOI":"10.3389\/fendo.2020.00643"},{"issue":"1","key":"1216_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11102-020-01086-4","volume":"24","author":"N Qiao","year":"2021","unstructured":"Qiao N, Shen M, He W, He M, Zhang Z, Ye H et al (2021) Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study. Pituitary 24(1):53\u201361","journal-title":"Pituitary"},{"issue":"11","key":"1216_CR37","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metabolism 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"11","key":"1216_CR38","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabolism 99(11):3933\u20133951. doi: https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"11","key":"1216_CR39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/bf03344070","volume":"25","author":"G Lombardi","year":"2002","unstructured":"Lombardi G, Colao A, Marzullo P, Biondi B, Palmieri E, Fazio S (2002) Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study. J Endocrinol Invest 25(11):971\u2013976 Epub 2003\/01\/30. doi: https:\/\/doi.org\/10.1007\/bf03344070. PubMed PMID: 12553557.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1216_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11102-019-00968-6","volume":"22","author":"O Polat Korkmaz","year":"2019","unstructured":"Polat Korkmaz O, Gurcan M, Nuhoglu Kantarci FE, Haliloglu O, Ozkaya HM, Sahin S et al (2019) The effects of pre-operative somatostatin analogue therapy on treatment cost and remission in acromegaly. Pituitary 22(4):387\u2013396 Epub 2019\/05\/18. doi: https:\/\/doi.org\/10.1007\/s11102-019-00968-6. PubMed PMID: 31098838.","journal-title":"Pituitary"},{"issue":"4","key":"1216_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrendo.2014.21","volume":"10","author":"A Giustina","year":"2014","unstructured":"Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemmons DR, Klibanski A et al (2014) Expert consensus document: a consensus on the medical treatment of acromegaly. Nat Reviews Endocrinol 10(4):243\u2013248","journal-title":"Nat Reviews Endocrinol"},{"issue":"2","key":"1216_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1210\/er.2010-0002","volume":"32","author":"A Colao","year":"2011","unstructured":"Colao A, Auriemma RS, Lombardi G, Pivonello R (2011) Resistance to somatostatin analogs in acromegaly. Endocr Rev 32(2):247\u2013271","journal-title":"Endocr Rev"},{"key":"1216_CR43","doi-asserted-by":"crossref","unstructured":"Chen T, editor Guestrin C, Mining D (2016) (KDD\u201916);","DOI":"10.2174\/138955751606160229124328"},{"issue":"1","key":"1216_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1145\/3359786","volume":"63","author":"M Du","year":"2019","unstructured":"Du M, Liu N, Hu X (2019) Techniques for interpretable machine learning. Commun ACM 63(1):68\u201377","journal-title":"Commun ACM"},{"issue":"4","key":"1216_CR45","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1677\/erc.0.0100611","volume":"10","author":"G Minniti","year":"2003","unstructured":"Minniti G, Jaffrain-Rea M, Esposito V, Santoro A, Tamburrano G, Cantore G (2003) Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocrine-related Cancer 10(4):611\u2013619","journal-title":"Endocrine-related Cancer"},{"key":"1216_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40618-020-01296-4","volume":"44","author":"M Araujo-Castro","year":"2021","unstructured":"Araujo-Castro M, Pascual-Corrales E, Mart\u00ednez-Vaello V, Baonza Saiz G, Qui\u00f1ones de Silva J, Acitores Cancela A et al (2021) Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission. J Endocrinol Investig 44:183\u2013193","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"1216_CR47","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3171\/2019.6.JNS191187","volume":"133","author":"MJ Asha","year":"2019","unstructured":"Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G et al (2019) Long-term outcomes of transsphenoidal surgery for management of growth hormone\u2013secreting adenomas: single-center results. J Neurosurg 133(5):1360\u20131370","journal-title":"J Neurosurg"},{"issue":"7","key":"1216_CR48","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1210\/jc.2008-0126","volume":"93","author":"A Fusco","year":"2008","unstructured":"Fusco A, Zatelli MC, Bianchi A, Cimino V, Tilaro L, Veltri F et al (2008) Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. J Clin Endocrinol Metabolism 93(7):2746\u20132750","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"1216_CR49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1530\/EJE-11-1119","volume":"166","author":"M Wang","year":"2012","unstructured":"Wang M, Mou C, Jiang M, Han L, Fan S, Huan C et al (2012) The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases. Eur J Endocrinol 166(5):797\u2013802","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1216_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3171\/2018.4.JNS18230","volume":"131","author":"J Rick","year":"2018","unstructured":"Rick J, Jahangiri A, Flanigan PM, Chandra A, Kunwar S, Blevins L et al (2018) Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes. J Neurosurg 131(1):147\u2013153","journal-title":"J Neurosurg"},{"issue":"3","key":"1216_CR51","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1210\/jc.2017-01844","volume":"103","author":"SH Park","year":"2018","unstructured":"Park SH, Ku CR, Moon JH, Kim EH, Kim SH, Lee EJ (2018) Age-and sex-specific differences as predictors of surgical remission among patients with acromegaly. J Clin Endocrinol Metabolism 103(3):909\u2013916","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"1216_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2265.2012.04492.x","volume":"78","author":"F Albarel","year":"2013","unstructured":"Albarel F, Castinetti F, Morange I, Conte-Devolx B, Gaudart J, Dufour H et al (2013) Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients. Clin Endocrinol 78(2):263\u2013270","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1216_CR53","doi-asserted-by":"publisher","first-page":"R223","DOI":"10.1530\/JME-14-0011","volume":"52","author":"D Cuevas-Ramos","year":"2014","unstructured":"Cuevas-Ramos D, Fleseriu M (2014) Somatostatin receptor ligands and resistance to treatment in pituitary adenomas. J Mol Endocrinol 52(3):R223\u2013R40","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"1216_CR54","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11102-012-0445-1","volume":"16","author":"J Brzana","year":"2013","unstructured":"Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2013) Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary 16(4):490\u2013498","journal-title":"Pituitary"},{"issue":"5","key":"1216_CR55","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","volume":"24","author":"MR Gadelha","year":"2013","unstructured":"Gadelha MR, Kasuki L, Korbonits M (2013) Novel pathway for somatostatin analogs in patients with acromegaly. Trends in Endocrinology & Metabolism 24(5):238\u2013246","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"7","key":"1216_CR56","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1210\/clinem\/dgab125","volume":"106","author":"LE Wildemberg","year":"2021","unstructured":"Wildemberg LE, da Silva Camacho AH, Miranda RL, Elias PC, de Castro Musolino NR, Nazato D et al (2021) Machine learning-based prediction model for treatment of acromegaly with first-generation somatostatin receptor ligands. J Clin Endocrinol Metabolism 106(7):2047\u20132056","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"4","key":"1216_CR57","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3171\/2014.10.Jns14496","volume":"122","author":"L Schwyzer","year":"2015","unstructured":"Schwyzer L, Starke RM, Jane JA Jr, Oldfield EH (2015) Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly. J Neurosurg 122(4):798\u2013802 Epub 2014\/11\/26. doi: https:\/\/doi.org\/10.3171\/2014.10.Jns14496. PubMed PMID: 25423276.","journal-title":"J Neurosurg"},{"issue":"24","key":"1216_CR58","first-page":"2558","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Acromegaly. New England. J Med 355(24):2558\u20132573","journal-title":"J Med"},{"issue":"11","key":"1216_CR59","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1210\/jc.2009-1311","volume":"94","author":"A Ben-Shlomo","year":"2009","unstructured":"Ben-Shlomo A, Schmid H, Wawrowsky K, Pichurin O, Hubina E, Chesnokova V et al (2009) Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy. J Clin Endocrinol Metabolism 94(11):4342\u20134350","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"1216_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000496753","volume":"108","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liu X, Hong X, Liu P, Bao X, Yao Y et al (2019) Prediction of recurrence after transsphenoidal surgery for Cushing\u2019s disease: the use of machine learning algorithms. Neuroendocrinology 108(3):201\u2013210","journal-title":"Neuroendocrinology"},{"key":"1216_CR61","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3389\/fnins.2018.01046","volume":"12","author":"X Wang","year":"2019","unstructured":"Wang X, Wang D, Yao Z, Xin B, Wang B, Lan C et al (2019) Machine learning models for multiparametric glioma grading with quantitative result interpretations. Front NeuroSci 12:1046","journal-title":"Front NeuroSci"},{"key":"1216_CR62","unstructured":"Lundberg SM, Lee S-I (eds) (2017) Proceedings of the 31st international conference on neural information processing systems;"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01216-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T10:43:51Z","timestamp":1675334631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01216-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01216-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"10 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors have nothing to disclose. Cem Sulu and Ayy\u00fcce Beg\u00fcm Bekta\u015f have equally contributed to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure Statement"}},{"value":"All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all living individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}